Canaan Partners raises $800M health tech funding
Canaan Partners raised $800 million in its 12th fund to back early-stage healthcare and technology companies, equaling the sum it picked up in its 11th...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Canaan Partners raised $800 million in its 12th fund to back early-stage healthcare and technology companies, equaling the sum it picked up in its 11th...
The longtime chief operating officer of one of the state’s four licensed medical marijuana growers is now also its president. Connecticut Pharmaceutical Solutions, which has...
The National Institutes of Health has provided research support to two members of the Yale School of Medicine faculty through its Rapid Acceleration of Diagnostics...
UConn recently funded five COVID-19 research projects and has announced plans for additional funding … more Separately, the longtime leader of UConn School of Medicine’s...
Connecticut Innovations has reported final investment figures from its recently completed fiscal year. Between July 1, 2019, and June 30, 2020, CI invested $43.2 million...
A study of 50 critically ill patients at Yale New Haven Hospital found a Guilford company’s portable MRI could successfully detect brain abnormalities at their...
A study of 50 critically ill patients at Yale New Haven Hospital found a Guilford company’s portable MRI could successfully detect brain abnormalities at their...
U.S. Senator Chris Murphy named Tangen Biosciences in Branford “Innovator of the Month” for September. Founded in 2013 by two Connecticut natives, Tangen’s goal has been to...
Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or $225.00 per share in cash. MyoKardia is a clinical-stage biopharmaceutical company discovering and developing targeted...
Sema4 has entered into a research agreement with Janssen Research & Development to optimize oncology clinical trials. Sema4 will provide Janssen access to two of...